NCT00123877View on ClinicalTrials.gov

Study of GPX-100 in the Treatment of Metastatic Breast Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions
Breast CancerMetastasis
Interventions
DRUG

GPX-100 (13-deoxydoxorubicin)

Trial Locations (3)

84112

Huntsman Cancer Center, University of Utah, Salt Lake City

Unknown

Sofia Cancer Center, Sofia

University Hospital Queen Joanna, Sofia

Sponsors
All Listed Sponsors
lead

Gem Pharmaceuticals

INDUSTRY